3 results
Primary Objective• To assess the effect of ALX148 + pembrolizumab + 5FU + platinum on 12-month overall survival (OS) rate and objective response rate (ORR)in patients with metastatic or unresectable, recurrent HNSCC who have not yet been treated…
There is need for evidence-based and reproducible data comparing the safety, longevity and patient satisfaction propensity of the various HA soft tissue filler products. In a survey among 67 Dutch cosmetic physicians in 2014, the Dutch National…
Our objectives in both adult and paediatric psoriasis patients are (I) To validate the Handheld LSCI Device for visualization of vascular changes within psoriatic plaques. (II) Identification of the most active and least active sides of psoriatic…